Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Yan Zheng, Dimitry M. Danilenko, Patricia Valdez et al. · Nature · 2006 · 1.8K citations

Inflammation, Cytokine, Il-23-induced Dermal Inflammation +9

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways

Kristine Nograles, Lisa C. Zaba, Emma Guttman‐Yassky et al. · British Journal of Dermatology · 2008 · 795 citations · Full text

Guidelines of care for the management of psoriasis and psoriatic arthritis

Alan Menter, Neil J. Korman, Craig A. Elmets et al. · Journal of the American Academy of Dermatology · 2009 · 474 citations

Rheumatology, Medicine, Clinical Dermatology +2

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

H. Bachelez, P.C.M. van de Kerkhof, Robert Strohal et al. · The Lancet · 2015 · 388 citations · Full text

Autoimmune Disease, Clinical Trials, Inflammatory Marker +7